MRI

• The world’s oldest conjoined twins, Lori and George Schappell, recently died, aged 62.
• Conjoined twins are incredibly rare, accounting for about one or two in every 100,000 births.
• Because conjoined twins are so rare, it is difficult to know exactly how they come about.

Types of conjoined twins

• There are 15 recognised types of conjoined twins, based on the various places their bodies fuse.
• Conjoined twins are usually picked up on routine ultrasound scans performed during pregnancy.
• Conjoined twins who are diagnosed by imaging are typically delivered by caesarean section.

Separating twins

• One of the longest operations to separate conjoined twins, who were fused at the cranium, took more than 100 hours.
• The earliest recorded attempt at surgical separation of conjoined twins dates back to AD945 in Armenia where conjoined brothers lived until middle age before one of them died.
• Separating conjoined twins requires a significant amount of planning before surgery can begin, including, of course, lots of imaging such as ultrasound, CT and MRI.
• Twins who share vital organs – or whose organs are fused – have a lower chance of a successful separation.

Adam Taylor does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

• Xlife Sciences is pleased to announce a collaboration between its portfolio company, FUSE-AI, and T-Systems Switzerland.
• T-Systems Switzerland, as a subsidiary of T-Systems International GmbH, is considered a system-relevant IT and digitalization partner in the healthcare sector in Switzerland.
• Through this cooperation, T-Systems Switzerland distributes the AI-based solution for prostate analysis from FUSE-AI centrally in Switzerland, thereby enabling the commercialization of «Prostate.Carcinoma.ai» for radiological clinics and practices.
• Xlife Sciences sees this partnership as a significant contribution to continuing its mission to bridge the gap between innovations and the needs of the healthcare market.

• VANCOUVER, British Columbia, April 05, 2024 (GLOBE NEWSWIRE) -- Pulsar Helium Inc. (TSXV:PLSR | OTCQB:PSRHF) (“Pulsar” or the “Company”) is pleased to announce that a recently filmed documentary featuring Pulsar’s team onsite during the drilling of the Jetstream #1 appraisal well at the Topaz helium project (USA, MN) has been published as a dedicated segment on reuters.com.
• Pulsar, whose assets are in the USA and Greenland, is the first private helium exploration company to work directly with the Reuters news network to highlight the critical importance of ‘safe jurisdiction’ domestically sourced primary helium.
• Almost all electronic devices require helium during manufacture, key lifesaving medical services including MRI scanners and breathing gasses also rely on a steady and reliable source of helium.
• Since this documentary was filmed Pulsar has identified helium contents of up to 13.8% at Topaz, making it one of the highest-grade discoveries in history.

• Moreover, the neflamapimod treatment effects on GFAP were correlated to clinical outcomes, assessed by the CDR-SB.
• Cash Position: As of December 31, 2023, CervoMed had $7.8 million in cash and cash equivalents as compared to $4.1 million as of December 31, 2022.
• This increase was attributed to the RewinD-LB Phase 2b clinical study in DLB which began in the first quarter of 2023.
• Net Loss: Net Loss was $2.2 million for the year ended December 31, 2023, compared to a net loss of $5.8 million for year ended December 31, 2022.